SCHEMBL6681341

SCHEMBL6681341

CCOc1nc(NCCCN2CCN(C)CC2)nc(OCC)c1NC(=O)c1ccc(Oc2cc(C(C)(C)C)ccc2C)o1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1F O60840 1/20 0.56
CHRM4 P08173 1/20 0.56
ADORA3 P0DMS8 1/20 0.56
CHRM1 P11229 1/20 0.56
CYP2C9 P11712 1/20 0.56
DRD1 P21728 1/20 0.56
DRD4 P21917 1/20 0.56
SLC6A2 P23975 1/20 0.56
HRH2 P25021 1/20 0.56
TACR1 P25103 1/20 0.56
PTAFR P25105 1/20 0.56
HTR2A P28223 1/20 0.56
HTR2C P28335 1/20 0.56
AGTR1 P30556 1/20 0.56
GNRHR P30968 1/20 0.56
SLC6A4 P31645 1/20 0.56
HTR7 P34969 1/20 0.56
OPRM1 P35372 1/20 0.56
DRD3 P35462 1/20 0.56
OPRK1 P41145 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4861887 0.86 GNRHR (0.61) CACNA1FCHRM4ADORA3CHRM1CYP2C9
SCHEMBL6665454 0.85 GNRHR (0.58) CACNA1FCHRM4ADORA3CHRM1CYP2C9
Acetic Acid SCHEMBL6670184 0.83 GNRHR (0.56) CACNA1FCHRM4ADORA3CHRM1CYP2C9
SCHEMBL4853341 0.83 GNRHR (0.66) CACNA1FCHRM4ADORA3CHRM1CYP2C9
SCHEMBL4862264 0.82 GNRHR (0.64) CACNA1FCHRM4ADORA3CHRM1CYP2C9
SCHEMBL4857447 0.82 GNRHR (0.61) CACNA1FCHRM4ADORA3CHRM1CYP2C9
SCHEMBL6668538 0.82 GNRHR (0.63) CACNA1FCHRM4ADORA3CHRM1CYP2C9
SCHEMBL4861088 0.80 GNRHR (0.68) CACNA1FCHRM4ADORA3CHRM1CYP2C9
SCHEMBL6639084 0.79 CYP2C9 (0.65) CACNA1FCHRM4ADORA3CHRM1CYP2C9
SCHEMBL4861341 0.78 GNRHR (0.66) CACNA1FCHRM4ADORA3CHRM1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401427-A4 NON-PEPTIDE GNRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM AGOURON PHARMA (US) 2004-12-01 EP disclosed
EP-1401427-A2 NON-PEPTIDE GNRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM Agouron Pharmaceuticals, Inc. (US) 2004-03-31 EP disclosed
WO-2002098363-A2 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM AGOURON PHARMACEUTICALS, INC. (US) 2002-12-12 WO disclosed